Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | PAM | P19021 | 2/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15844825 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15844908 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15844955 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15844902 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL17026005 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15844859 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15844796 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL17026109 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL15845090 | 1.00 | DGKA (0.48) | DGKAALDH1A1TSHRCYP3A4PRSS1 | |
| SCHEMBL218168 | 0.98 | DGKA (0.45) | DGKAALDH1A1TSHRCYP3A4PRSS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7674842-B2 | Phase change inks containing curable isocyanate-derived compounds and phase change inducing components | XEROX CORPORATION (US) | 2010-03-09 | — | — | US | claimed |
| US-7449515-B2 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION (US) | 2008-11-11 | — | — | US | claimed |
| US-8915993-B2 | Solid or phase change inks with improved properties | XEROX CORPORATION (US) | 2014-12-23 | — | — | US | disclosed |
| US-8915993-B2 | Solid or phase change inks with improved properties | XEROX CORPORATION (US) | 2014-12-23 | — | — | US | disclosed |
| US-20140338563-A1 | Solid Or Phase Change Inks With Improved Properties | XEROX CORPORATION | 2014-11-20 | — | — | US | disclosed |
| US-20140338563-A1 | Solid Or Phase Change Inks With Improved Properties | XEROX CORPORATION | 2014-11-20 | — | — | US | disclosed |
| US-20140338563-A1 | Solid Or Phase Change Inks With Improved Properties | XEROX CORPORATION | 2014-11-20 | — | — | US | disclosed |
| US-20120227621-A1 | SOLID OR PHASE CHANGE INKS WITH IMPROVED PROPERTIES | XEROX CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| US-20120227621-A1 | SOLID OR PHASE CHANGE INKS WITH IMPROVED PROPERTIES | XEROX CORPORATION (US) | 2012-09-13 | — | — | US | disclosed |
| US-20100313788-A1 | SOLID OR PHASE CHANGE INKS WITH IMPROVED PROPERTIES | XEROX CORPORATION (US) | 2010-12-16 | — | — | US | disclosed |
| US-20100313788-A1 | SOLID OR PHASE CHANGE INKS WITH IMPROVED PROPERTIES | XEROX CORPORATION (US) | 2010-12-16 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123642-A1 | Phase change inks containing curable isocyanate-derived compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123601-A1 | Curable phase change compositions and methods for using such compositions | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123641-A1 | Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |
| US-20070123601-A1 | Curable phase change compositions and methods for using such compositions | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070120908-A1 | Phase change inks | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |
| US-20070120908-A1 | Phase change inks | XEROX CORPORATION (US) | 2007-05-31 | — | — | US | disclosed |